Tuberculosis elimination and laboratory cooperative agreement - the SAN francisco tuberculosis prevention and control program (sftbpcp) is the lead agency for tuberculosis (TB) prevention and…

Tuberculosis elimination and laboratory cooperative agreement - the SAN francisco tuberculosis prevention and control program (sftbpcp) is the lead agency for tuberculosis (TB) prevention and control in the city and county of SAN francisco (ccsf), california (population 848,019). The mission of the sftbpcp is to control, prevent, and finally eliminate tuberculosis in SAN francisco by providing compassionate, equitable, and supportive care of the highest quality to all persons affected by this disease. In order to achieve these goals, the sftbpcp provides: direct patient care in the SAN francisco TB clinic to individuals with active TB and their contacts as well as medically or socially complex patients needing risk-based TB screening or latent TB infection (ltbi) treatment supported by SAN francisco public health laboratory (PHL) services; expert technical assistance, education, and training to academic, public health and private sector providers; investigation of all case exposures to ensure TB control; strategic planning and leadership through policy and guideline development; and performs TB surveillance, data analysis and program evaluation; and information resources for TB in ccsf for local, state and national stakeholders. The overarching challenge for sftbpcp is to screen for, diagnose and manage active and latent TB in these medically and socially-complex populations. Tuberculosis elimination and laboratory cooperative agreement CDC-RFA-PS-25-0003 funds will be used to augment essential public health TB prevention, control, elimination, surveillance, human resource development (HRD), program evaluation and management, and laboratory activities as detailed in this application. Funding for prevention and control (p & c) and laboratory strengthening will allow sftbpcp to continue progress towards short-term and intermediate-term outcomes that will result in decreased incidents of TB in general and in particular in populations at higher risk. Sftbpcp will use the 2025 national TB program (ntip) objectives and performance targets, california TB prevention and control objectives and targets (2025 - 2029), and national TB laboratory turnaround time (TAT) performance targets as a framework to outline target outcomes for 2025 - 2029.